18 GHz Solidly Mounted Resonator in Scandium Aluminum Nitride on SiO2/Ta2O5 Bragg Reflector
Authors:
Omar Barrera,
Nishanth Ravi,
Kapil Saha,
Supratik Dasgupta,
Joshua Campbell,
Jack Kramer,
Eugene Kwon,
Tzu-Hsuan Hsu,
Sinwoo Cho,
Ian Anderson,
Pietro Simeoni,
Jue Hou,
Matteo Rinaldi,
Mark S. Goorsky,
Ruochen Lu
Abstract:
This work reports an acoustic solidly mounted resonator (SMR) at 18.64 GHz, among the highest operating frequencies reported. The device is built in scandium aluminum nitride (ScAlN) on top of silicon dioxide (SiO2) and tantalum pentoxide (Ta2O5) Bragg reflectors on silicon (Si) wafer. The stack is analyzed with X-ray reflectivity (XRR) and high-resolution X-ray diffraction (HRXRD). The resonator…
▽ More
This work reports an acoustic solidly mounted resonator (SMR) at 18.64 GHz, among the highest operating frequencies reported. The device is built in scandium aluminum nitride (ScAlN) on top of silicon dioxide (SiO2) and tantalum pentoxide (Ta2O5) Bragg reflectors on silicon (Si) wafer. The stack is analyzed with X-ray reflectivity (XRR) and high-resolution X-ray diffraction (HRXRD). The resonator shows a coupling coefficient (k2) of 2.0%, high series quality factor (Qs) of 156, shunt quality factor (Qp) of 142, and maximum Bode quality factor (Qmax) of 210. The third-order harmonics at 59.64 GHz is also observed with k2 around 0.6% and Q around 40. Upon further development, the reported acoustic resonator platform can enable various front-end signal-processing functions, e.g., filters and oscillators, at future frequency range 3 (FR3) bands.
△ Less
Submitted 2 July, 2024;
originally announced July 2024.
Rotor Localization and Phase Map** of Cardiac Excitation Waves using Deep Neural Networks
Authors:
Jan Lebert,
Namita Ravi,
Flavio Fenton,
Jan Christoph
Abstract:
The analysis of electrical impulse phenomena in cardiac muscle tissue is important for the diagnosis of heart rhythm disorders and other cardiac pathophysiology. Cardiac map** techniques acquire local temporal measurements and combine them to visualize the spread of electrophysiological wave phenomena across the heart surface. However, low spatial resolution, sparse measurement locations, noise…
▽ More
The analysis of electrical impulse phenomena in cardiac muscle tissue is important for the diagnosis of heart rhythm disorders and other cardiac pathophysiology. Cardiac map** techniques acquire local temporal measurements and combine them to visualize the spread of electrophysiological wave phenomena across the heart surface. However, low spatial resolution, sparse measurement locations, noise and other artifacts make it challenging to accurately visualize spatio-temporal activity. For instance, electro-anatomical catheter map** is severely limited by the sparsity of the measurements, and optical map** is prone to noise and motion artifacts. In the past, several approaches have been proposed to obtain more reliable maps from noisy or sparse map** data. Here, we demonstrate that deep learning can be used to compute phase maps and detect phase singularities in optical map** videos of ventricular fibrillation, as well as in very noisy, low-resolution and extremely sparse simulated data of reentrant wave chaos mimicking catheter map** data. The deep learning approach learns to directly associate phase maps and the positions of phase singularities with short spatio-temporal sequences of electrical data. We tested several neural network architectures, based on a convolutional neural network with an encoding and decoding structure, to predict phase maps or rotor core positions either directly or indirectly via the prediction of phase maps and a subsequent classical calculation of phase singularities. Predictions can be performed across different data, with models being trained on one species and then successfully applied to another, or being trained solely on simulated data and then applied to experimental data. Future uses may include the analysis of optical map** studies in basic cardiovascular research, as well as the map** of atrial fibrillation in the clinical setting.
△ Less
Submitted 8 November, 2021; v1 submitted 21 September, 2021;
originally announced September 2021.
